ICGT ICG Enterprise Trust

ICG Enterprise Trust Plc: Notification of Share Transaction

ICG Enterprise Trust Plc: Notification of Share Transaction

ICG Enterprise Trust Plc: Notification of Transactions of Persons Discharging Managerial Responsibilities

ICG ENTERPRISE TRUST PLC (the “Company”)

6 May 2020

Notification of Transactions of Persons Discharging Managerial Responsibilities



This announcement is made pursuant to Article 19 of the Market Abuse Regulation.

The Company wishes to announce that it received notification on 5 May 2020 that Sandra Pajarola, a Non-Executive Director, bought a 5,000 ordinary shares in the Company at an average price of 700 pence per share.

As a result of this transaction Sandra Pajarola and her connected persons hold a total of 25,000 ordinary shares, being 0.03% of the ordinary share capital of the Company (excluding treasury shares).

Contacts

Investor Enquiries:

Ian Stanlake

Head of Investor Relations

+44 (0) 20 3201 7700

Media Enquiries:

Vikki Kosmalska

Associate Partner, Maitland

+44 (0) 20 7379 5151

EN
06/05/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ICG Enterprise Trust

 PRESS RELEASE

Director/PDMR Shareholding

Director/PDMR Shareholding ICG Enterprise Trust plc (the “Company”) 2 April 2026 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them The Company received notification on 1 April 2026 that Jane Tufnell, Chair, transferred 13,283 ordinary shares in the Company ("Shares") from a General Investment Account (“GIA”) to an Individual Savings Account (“ISA”), and that she transferred 6,380 Shares to a person closely associated (“PCA”) with her, who subsequently transferred those 6,380 Shares from a GIA to ...

Mark Thomas ... (+3)
  • Mark Thomas
  • Martin Hall
  • Mike Foster

Hardman & Co Monthly: April 2026

Feature article: 2025 pharma statistics, by Dr Martin Hall, Head of Life Sciences at Hardman & Co Our pharmaceutical dataset has been compiled over 40 years from 109 companies, which, through M&A activity and consolidation, now comprise 46 companies. An efficient reporting system has seen all the listed multinational pharma companies announce results for 2025, giving us the opportunity to update our industry statistics and drug database. This report provides the first snapshot of global pharmac...

 PRESS RELEASE

Voting Rights and Capital

Voting Rights and Capital ICG Enterprise Trust plc (the “Company”) 1 April 2026 Total Voting Rights In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R, the Company announces as follows. At the close of business on 31 March 2026, the Company had 63,554,192 Ordinary shares in issue, of which 2,074,106 were held in Treasury. Therefore, the total number of voting rights in the Company is 61,480,086.The above figure 61,480,086 may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their intere...

 PRESS RELEASE

Transaction in Own Shares

Transaction in Own Shares ICG Enterprise Trust plc (the “Company”) 31 March 2026 Transaction in Own Shares The Company announces that on 30 March 2026 it bought back 15,000 of its own shares, to be held as treasury shares, at an average price of 1330 pence per share. Further details are set out below: Number of shares held as treasury shares following settlement of this purchase: 2,089,106Total shares in issue excluding treasury shares following settlement of this purchase: 61,465,086 The Company has bought back these shares under the authority granted by shareholders at i...

 PRESS RELEASE

Transaction in Own Shares

Transaction in Own Shares ICG Enterprise Trust plc (the “Company”) 25 March 2026 Transaction in Own Shares The Company announces that on 24 March 2026 it bought back 15,000 of its own shares, to be held as treasury shares, at an average price of 1327 pence per share. Further details are set out below: Number of shares held as treasury shares following settlement of this purchase: 2,074,106Total shares in issue excluding treasury shares following settlement of this purchase: 61,480,086 The Company has bought back these shares under the authority granted by shareholders at its Annual Ge...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch